炎症性肠病
血清学
溃疡性结肠炎
疾病
临床表型
医学
内科学
免疫学
表型
生物
遗传学
抗体
基因
作者
Mark S. Silverberg,Jack Satsangi,Tariq Ahmad,Ian Arnott,Çharles N. Bernstein,Steven R. Brant,R. Caprilli,Jean–Frédéric Colombel,Christoph Gasché,Karel Geboes,D P Jewell,Amir Karban,Edward V. Loftus,A. S. Peña,Robert H. Riddell,David B. Sachar,Stefan Schreiber,A. Hillary Steinhart,Stephan R. Targan,Séverine Vermeire,Bryan F. Warren
摘要
The discovery of a series of genetic and serological markers associated with disease susceptibility and phenotype in inflammatory bowel disease has led to the prospect of an integrated classification system involving clinical, serological and genetic parameters. The Working Party has reviewed current clinical classification systems in Crohn’s disease, ulcerative colitis and indeterminate colitis, and provided recommendations for clinical classification in practice. Progress with respect to integrating serological and genetic markers has been examined in detail, and the implications are discussed. While an integrated system is not proposed for clinical use at present, the introduction of a widely acceptable clinical subclassification is strongly advocated, which would allow detailed correlations among serotype, genotype and clinical phenotype to be examined and confirmed in independent cohorts of patients and, thereby, provide a vital foundation for future work.
科研通智能强力驱动
Strongly Powered by AbleSci AI